LTBP2 and interstitial lung disease: Consistent with these findings, we found that fibrotic mice lungs and lung samples originating from IPF and RA-ILD patients exhibited increases in the activated fibroblasts/myofibroblasts marker, and this pathological change was accompanied by increased LTBP2 expression.